GlassScriptPhysician profile
Isaac Dushane Crawford
NPI 1225665474
$1,726.14
in general payments reported to CMS, 2019-2025
15 companies · $816 in 2025
The $816 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $160 · 2024: $750 · 2025: $816.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,726.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $430.51 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $190.55 | 2023-2025 | |
| Glaxosmithkline, LLC. | $188.55 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $181.48 | 2023-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $130.41 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Viiv Healthcare Company | $128.14 | 2024-2025 | Apretude, Cabenuva |
| Abbvie INC. | $99.39 | 2025 | |
| Merck Sharp & Dohme LLC | $76.97 | 2024-2025 | Pifeltro, Delstrigo, Dificid |
| Theratechnologies INC. | $74.17 | 2023-2025 | Trogarzo, Egrifta |
| Dexcom, INC. | $65.33 | 2024-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $60.54 | 2025 | Wegovy, Ozempic |
| Abbott Laboratories | $48.00 | 2024-2025 | Freestyle Libre |
| Axsome Therapeutics, INC. | $20.06 | 2025 | Auvelity |
| Antares Pharma, INC. | $17.99 | 2025 | Xyosted |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.05 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isaac Crawford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.